Delivery Order SPE2DB22D1017-SPE2DB25FG7YS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) valued at $2,912.46. This non-competitive, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly used to treat depression and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,930.56 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Escitalopram 10 mg, a generic selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,819.74 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg on July 29, 2025, with a ceiling value of $2,187.18 and an ultimate completion date of July 30, 2025. The contract carries a firm fixed price with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, a selective serotonin reuptake inhibitor commonly used to treat depression and anxiety disorders. This competitive, non-set-aside delivery order was issued on September 15, 2025, with a ceiling value of $10,696.65 and a firm fixed-price structure. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. This firm fixed price delivery order, valued at $1,096.85, was competitively awarded without set-aside provisions and is scheduled for completion by August 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,884.40 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with completion required by September 9, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 units) under a firm fixed-price contract valued at $1,740.43. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7YSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,507.57 to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorder treatment within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen regularly fulfills critical medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, maintaining an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/23/25 |